Best Practice in Toxicological Pathology

作者: M.M. Abdi

DOI: 10.1016/B978-0-12-803620-4.00015-3

关键词:

摘要: Abstract Toxicological pathology is a critical component of the safety assessment new drug candidates in preclinical studies. The identification, characterization, and interpretation drug-induced histopathological changes require trained pathologists technical staff who generate high-quality necropsy microscopic data communicate an integrated report including clinical organ weights. are recorded consistent manner using internationally agreed standardized nomenclature diagnostic terms grading severity lesion and, where necessary, stating distribution lesion. It role pathologist to distinguish between lesions that either spontaneous unknown cause or represent normal morphological variations tissue at different functional phases, induced by test article under assessment. In latter case, also determines adversity otherwise with study director, helps establish no-observed-adverse-effect-level (NOAEL) on weight-of-evidence basis. standardization necropsy, collection processing, use histopathology, together robust peer review, guarantee quality, consistency, integrity their interpretation. best practices strictly adhere guidelines Standard Operating Procedures (SOPs). purpose this chapter describe processes procedures toxicological necessary for generation valid results interpretation, highlight examples some common test-article-induced encountered standard toxicity Clinical parameters will be mentioned only when relevant consideration.

参考文章(137)
Peter Clements, Sally Brady, Malcolm York, Brian Berridge, Igor Mikaelian, Rosemary Nicklaus, Mitul Gandhi, Ian Roman, Clare Stamp, Dai Davies, Paul McGill, Thomas Williams, Syril Pettit, Dana Walker, John Turton, , Time course characterization of serum cardiac troponins, heart fatty acid - Binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat Toxicologic Pathology. ,vol. 38, pp. 703- 714 ,(2010) , 10.1177/0192623310374969
Chandikumar S. Elangbam, Drug-induced valvulopathy: an update. Toxicologic Pathology. ,vol. 38, pp. 837- 848 ,(2010) , 10.1177/0192623310378027
Richard W. Lewis, Richard Billington, Eric Debryune, Armin Gamer, B. Lang, Francis Carpanini, Recognition of Adverse and Nonadverse Effects in Toxicity Studies Toxicologic Pathology. ,vol. 30, pp. 66- 74 ,(2002) , 10.1080/01926230252824725
K. D. Chadwick, A. M. Fletcher, M. C. Parrula, S. Bonner-Weir, R. S. Mangipudy, E. Janovitz, M. J. Graziano, D. Roy, T. P. Reilly, Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapies Diabetes. ,vol. 63, pp. 1303- 1314 ,(2014) , 10.2337/DB13-1268
Gary A. Boorman, Douglas C. Wolf, Sabine Francke-Carroll, Robert R. Maronpot, Pathology Peer Review Toxicologic Pathology. ,vol. 38, pp. 1009- 1010 ,(2010) , 10.1177/0192623310385361
Marc G Sturgill, George H Lambert, Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function Clinical Chemistry. ,vol. 43, pp. 1512- 1526 ,(1997) , 10.1093/CLINCHEM/43.8.1512
Chennekatu P. Peter, Joe D. Burek, Matthew J. Van Zwieten, Spontaneous Nephropathies in Rats Toxicologic Pathology. ,vol. 14, pp. 91- 100 ,(1986) , 10.1177/019262338601400111
John L. Robertson, Spontaneous renal disease in dogs. Toxicologic Pathology. ,vol. 14, pp. 101- 108 ,(1986) , 10.1177/019262338601400112
John E. Burkhardt, Anne M. Ryan, Paul-Georg Germann, Practical Aspects of Discovery Pathology Toxicologic Pathology. ,vol. 30, pp. 8- 10 ,(2002) , 10.1080/01926230252824653